SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-21-006717
Filing Date
2021-09-27
Accepted
2021-09-27 16:16:34
Documents
79
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ipix_10k.htm 10-K 1162853
2 CONSENT ipix_ex231.htm EX-23.1 2837
3 CERTIFICATION ipix_ex311.htm EX-31.1 9928
4 CERTIFICATION ipix_ex321.htm EX-32.1 4221
  Complete submission text file 0001477932-21-006717.txt   5495826

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ipix-20210630.xml EX-101.INS 830076
6 XBRL TAXONOMY EXTENSION SCHEMA ipix-20210630.xsd EX-101.SCH 94700
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipix-20210630_lab.xml EX-101.LAB 439625
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipix-20210630_cal.xml EX-101.CAL 49999
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipix-20210630_pre.xml EX-101.PRE 390983
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipix-20210630_def.xml EX-101.DEF 285500
Mailing Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880
Business Address 301 EDGEWATER PLACE SUITE 100 WAKEFIELD MA 01880 978-921-4125
Innovation Pharmaceuticals Inc. (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 300565645 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-37357 | Film No.: 211281920
SIC: 2834 Pharmaceutical Preparations